Home | Careers | Contact Us | Location Map | Sign In
   
 
   
 
 
 
Home >> Medical Zone > Enivac
E-mail this page Print this page
ENIVAC
 
  • Kar P, JandwaniP., Khurana V., et al.
    Seroconversion with rDNA hepatitis B vaccine of Cuban origin.
    Indian Journal of Gastroenterology, 1997; 16(4): 161.
  • Sethi G. R., Sharma S., Sudha S. and Rishi R. K.
    Immunogenicity of Recombinant Hepatitis B Vaccine in thalassemic Children.
    Indian Pediatrics, May 1999; 36: 498-501.
  • Sanjay Singh and Dr. Deepika R. Sharma.
    Tolerability of a recombinant DNA Hepatitis B Vaccine - Result of Post-Marketing Surveillance.
    Journal of Communicable Diseases, March 1999; 31(1): 53-55.
  • Kunal Das, R. K. Gupta, B. K. Sharma, V. Kumar, S. Singh & Kar P.,
    Evaluation of immunogenicity and reactogenicity of rDNA Hepatitis B Vaccine in subjects over the age of forty years.
    Oral Presentation in Indian Association for study of the liver. Pg. 24.
  • Kunal Das, P. Kar, Sanjay Singh, V. Kumar & B. K. Sharma.
    HLA phenotype and response to a single booster dose in non-responders to hepatiits B vaccination among age group more than forty years in North Indians.
    Poster presentation in 11th asian-pacific congress of gastroentrology. 8th Asian pacific congress of digestive endoscopy, March 10-14, 2000, Hong Kong, China, Pg.B32. Abstract No.A87.
  • Jain A., Jandwani P., Gupta R. K., Kumar V. Mathur U.S. and Kar P.
    A Multicentric evaluation recombinant DNA Hepatitis B vaccine of Cuban origin.
    Tropical gastroenerology, 2000 (Jan- Mar); 21(1): 14 -17
  • Kaur Harjeet, Mani A.
    Seroprotection following Enivac-HB, a recombinant hepatitis B Vaccine (Letter)
    Indian Journal of Gastroenterology; 2000; 19(1): 41.